RxDoctor Payments Data

David Kinker

Nurse Practitioner · Jacksonville, FLNPI 1588346332

Payments from drug & device makers

$3,451in general payments, 2019–2025

Across 142 payments — averaging $24.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$529
  • Novartis$335
  • United Therapeutics Corporation$329
  • Actelion Pharmaceuticals US, Inc.$307
  • Johnson & Johnson$290
  • Boehringer Ingelheim$225
  • plus $1K from 19 others

What the payments were for

  • Food & beverage$3,38498%
  • Education$672%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,451 in reported general payments places this provider in the 85th percentile of 8,290 nurse practitioner providers in Florida.

See all nurse practitioner providers in Florida

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban92$103,692
XareltoRivaroxaban76$94,882
JardianceEmpagliflozin45$55,237
EntrestoSacubitril/Valsartan21$40,602
Repatha SureclickEvolocumab32$35,143
FarxigaDapagliflozin Propanediol27$31,506
VerquvoVericiguat20$16,470
Ranolazine ErRanolazine35$2,605
Rosuvastatin Calcium138$2,277
Metoprolol Succinate127$1,906
Ezetimibe59$1,661
Losartan Potassium135$1,417
Isosorbide Mononitrate ErIsosorbide Mononitrate61$711
Amiodarone Hcl24$664
Metoprolol Tartrate47$577

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$196$103,69292 claims
Johnson & JohnsonXarelto$290$94,88276 claims
Boehringer IngelheimJardiance$225$55,23745 claims
NovartisEntresto$335$40,60221 claims
AstraZenecaFarxiga$91$31,50627 claims
MerckVerquvo$529$16,47020 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 8,290 nurse practitioner providers in Florida.

Other nurse practitioner in Jacksonville

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →